•
MR
MRNA
Moderna, Inc. Common Stock
polygonBIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
--
Price Chart
Market Cap
19.46B
Volume
5.61M
52W High
$52.57
52W Low
$22.28
Open
$50.24
Prev Close
$49.81
Day Range
50.05 - 52.69
About Moderna, Inc. Common Stock
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Latest News
Stock Market Today: S&P 500, Dow Jones, Nasdaq 100 Futures Rise As BEA Pegs Q3 GDP At 4.4%— Microsoft, Moderna, Intel In Focus (UPDATED)
Benzinga•1h ago
Moderna Stock Rallies as Oncology Results Improve the Platform’s Value Case
Investing.com•19h ago
Stocks Rebound On Trump's Remarks, Natural Gas Rockets: What's Moving Markets Wednesday?
Benzinga•20h ago
Moderna Pops 17%—Is There Life in MRNA, Down 90% from COVID High?
Investing.com•22h ago
Moderna–Merck Cancer Vaccine Shows Durable Benefit At 5 Years In High-Risk Melanoma
Benzinga•Yesterday
Silver Jumps To $89 After Soft CPI, JPMorgan Falls 3%: What's Moving Markets Tuesday?
Benzinga•Jan 13
My Top 5 Stocks to Buy in Early 2026
The Motley Fool•Jan 7
Silver Jumps 6%, Platinum Up 8%, Palladium Up 11% As Metal Shock Erupts: What's Moving Markets Friday?
Benzinga•Dec 26